3rd March 2021
07:01

4d Pharma PLC - Investor conference participation

1st March 2021
17:49

4d Pharma PLC - Exercise of Options and Total Voting Rights

1st March 2021
07:07

4d Pharma PLC - John Beck Appointed as Chief Financial Officer

1st March 2021
07:05

4d Pharma PLC - Appoints Paul Maier to the Board as NED

26th February 2021
16:00
26th February 2021
12:52

4d Pharma PLC - Holding(s) in Company

26th February 2021
07:05

4d Pharma PLC - Posting of Circular

26th February 2021
07:00

4d Pharma PLC - U.S. SEC Declares Registration Statement Effective

16th February 2021
09:49
16th February 2021
07:02

4d Pharma PLC - Microbiome Leaders Panel Event

8th February 2021
09:38
8th February 2021
07:45

4d Pharma PLC - Holding(s) in Company

8th February 2021
07:01

4d Pharma PLC - Oncology Clinical Collaboration

4th February 2021
14:55

4d Pharma PLC - Holding(s) in Company

3rd February 2021
09:59
3rd February 2021
07:02

4d Pharma PLC - Oncology Program Update

1st February 2021
14:10

4d Pharma PLC - Total Voting Rights

27th January 2021
07:00

4d Pharma PLC - Holding(s) in Company

25th January 2021
18:01

4d Pharma PLC - Holding(s) in Company

4D Pharma Plc
DDDD.L
4D Pharma Plc
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    109.49M

Company Profile

We are pioneers in harnessing bacteria as a novel and revolutionary class of medicines: Live Biotherapeutics

Classification

Market Indices-
Watchlist